Results 81 to 90 of about 33,657 (222)

Current Dengue Virus Vaccine Developments and Future Directions

open access: yesViruses
Dengue fever (DF), a leading arboviral disease globally, is caused by the Dengue virus (DENV) and represents a significant public health concern, with an estimated 390 million cases reported annually.
Govindaraj Anumanthan   +2 more
doaj   +1 more source

Development of dengue vaccine by using plga microparticle adsorbed with dengue subunit protein

open access: yes, 2016
[[abstract]]Aims: Poly lactic-co-glycolic acid (PLGA) is a biocompatible and biodegradable material used in many biomedical applications, including bioactive agent delivery.
Pan, CH;Hsieh, CH
core   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

open access: yesTransplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez   +16 more
wiley   +1 more source

Dengue epidemic characteristics and vaccine research progress: a review

open access: yesZhongguo gonggong weisheng
Dengue fever is a mosquito-borne viral infectious disease transmitted by Aedes mosquitoes carrying the dengue virus (DENV). It is currently prevalent in over 100 tropical and subtropical countries and regions, and was listed by the WHO as one of the "Top
Jun LIU   +6 more
doaj   +1 more source

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning

open access: yesNature Communications, 2018
Clinical trials for the CYD-TDV dengue vaccine showed that vaccine efficacy varies with prior dengue exposure, but baseline serostatus is only known for 12% of subjects. Here, Dorigatti et al.
I. Dorigatti   +6 more
doaj   +1 more source

Assessing the potential of a candidate dengue vaccine with mathematical modeling [PDF]

open access: yes, 2012
Dengue viruses are single-stranded positive-sense RNA viruses (genus Flavivirus, family Flaviviridae) that are the etiological agents of dengue fever (DF).
WHO-VMI Dengue Vaccine Modeling Group   +1 more
core  

Impact on health caused by water resources development and management projects and health impact assessment as a tool for mitigation [PDF]

open access: yes, 2007
Since the rise of early civilisations people have adapted and modified water bodies for their use. Water is made available through dams, wells, canals and other infrastructure to provide drinking water for households and livestock and to feed irrigated
Erlanger, Tobias Ephraim
core   +1 more source

Co‐infection of Hepatitis A and E With Atypical Manifestation: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Hepatitis A virus (HAV) and hepatitis E virus (HEV) are common causes of acute viral hepatitis in developing countries where inadequate sanitation and contaminated water supplies facilitate fecal–oral transmission. Although both infections are usually self‐limiting, co‐infection may result in atypical presentations and pose diagnostic ...
Umaimah Batool Mirza   +4 more
wiley   +1 more source

Overview of Plant-Derived Vaccine Antigens: Dengue Virus

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2011
- This review highlights the advantages and current status of plant-derived vaccine development with special reference to the dengue virus. There are numerous problems involved in dengue vaccine development, and there is no vaccine against all four ...
Ravindra B Malabadi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy